Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1348636

	registered interest
	date	20/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the demographic breakdown of people who have been hospitalised with covid-19 after receiving (a) one and (b) two doses of a vaccine.
	tabling member constituency	Birmingham, Edgbaston
	tabling member printed	Preet Kaur Gill
	uin	36724
	answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>Public Health England publishes the age and sex breakdown of hospitalisations for COVID-19 for the most recent four week period on a weekly basis at the following link:</p><p><a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fstatistics%2Fnational-flu-and-covid-19-surveillance-reports-2021-to-2022-season&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cd8a5d4ca5e2f4eec8d8208d94c3161e0%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637624597245146774%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=BkHeLCF%2BjpJrbhFP464Z7rzY3nC%2BJubS5l4XJFMrOK8%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season</a></p><p>The analysis is based on data from a sentinel network of acute National Health Service trusts contributing enhanced data.</p><p>PHE publishes technical briefings which provide the latest data regarding hospitalisations and deaths by variant, including the Delta variant, as well as data concerning those hospitalised with the Delta variant of COVID-19 who are vaccinated with one and both doses and unvaccinated. These data are retrospective and do not represent current hospitalisations. Data is available from 1 February 2021 at the following link:</p><p><a href="https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201" target="_blank">https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 15:51:12 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18922 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4603 label Biography information for Preet Kaur Gill

1348754

	registered interest
	date	20/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether it is his policy to ensure that in any booster vaccine programme third doses of covid-19 vaccines are prioritised for people who are immunosuppressed in (a) Newcastle upon Tyne and (b) other areas with a number of cases.
	tabling member constituency	Newcastle upon Tyne East
	tabling member printed	Mr Nicholas Brown
	uin	36530
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) recognises that some individuals who are severely immunosuppressed due to underlying health conditions or medical treatment may not achieve the same full immune response to the initial two dose COVID-19 vaccination course as those who are not immunosuppressed. The committee has therefore advised on 1 September that as a precautionary measure those with severe immunosuppression at or around the time of their first or second dose of COVID-19 vaccination should receive a third dose. The aim is to raise the level of immunity in these individuals closer to the level of immunity as the non-immunosuppressed achieve from two doses in Newcastle upon Tyne and other areas.</p><p>The Government has accepted this advice, which will be applied at a national level. Severe immunosuppression at the time of vaccination is defined using guidance and timings outlined at the following link:</p><p><a href="https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination" target="_blank">https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination</a></p><p>The purpose of the separate potential booster programme is to maximise protection in those who are most vulnerable to serious COVID-19 ahead of the winter months. The JCVI published interim advice on a potential Covid-19 booster vaccination programme on 30 June 2021, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p><p>It is expected that severely immunosuppressed individuals will become eligible for a booster dose as part of any routine booster programme from around six months after their third dose, pending further advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:33:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18935 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	523 label Biography information for Mr Nicholas Brown

1349118

	registered interest
	date	21/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the covid-19 vaccine app will be changed to enable people of 17 years and 9 months to book a vaccine appointment.
	tabling member constituency	Putney
	tabling member printed	Fleur Anderson
	uin	37602
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>A COVID-19 vaccine app which allows vaccine appointments to be booked in the United Kingdom does not exist. COVID-19 vaccinations can be booked via the National Booking System which can be accessed online or by calling 119, or alternatively, by booking through an individual’s General Practice. On 12 August 2021, SMS messages were sent to all individuals aged over 17 years and 9 months inviting them to book their COVID-19 vaccination appointment.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 14:41:48 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4788 label Biography information for Fleur Anderson

1349570

	registered interest
	date	22/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the Government plans to publish the impact assessment on making covid-19 vaccination a condition of deployment in care homes; and what engagement is planned with the social care sector on that matter.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	38354
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38355 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18938 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4510 label Biography information for Helen Hayes

1349571

	registered interest
	date	22/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Statement of impact – The Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021 updated 19 July 2021 and the estimated of £100 million for making vaccination a condition of deployment in care homes, how that cost will be funded; and what (a) legal and (b) employment expertise will be made available to care home providers to implement that policy.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	38355
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38354 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18944 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4510 label Biography information for Helen Hayes

1350856

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	New Businesses: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support start-ups in the manufacturing sector.
	tabling member constituency	Wolverhampton South West
	tabling member printed	Stuart Anderson
	uin	41272
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is committed to supporting UK manufacturing businesses, including start-ups and recognises the vital role they play in the UK economy, by driving innovation, exports, job creation and productivity growth.</p><p> </p><p>We are committed to supporting manufacturers to take advantage of innovative technology and we recently announced <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2F8-million-government-boost-for-manufacturers-across-england-to-go-digital&amp;data=04%7C01%7Cfilder.onek%40beis.gov.uk%7Caa8df0a9fa1b47253ef508d966631201%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637653397946777930%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JbjtVD2pKuArzY4hKwXd7ZbWr5lCJDL85VcFmQvt5pw%3D&amp;reserved=0" target="_blank">£8 million in new government funding for the Made Smarter Adoption programme to help Small and Medium Sized Enterprises (SMEs</a>) increase productivity, competitiveness and drive up efficiency by adopting industrial digital technology, building on the success of our Made Smarter North West Pilot.</p><p> </p><p>The Government’s business support schemes have been put in place to help eligible businesses to get through the pandemic, from all regions and backgrounds. Information on these schemes and other resources is available via the free Business Support Helpline.</p><p> </p><p>The Start Up Loans Company, part of the Government-owned British Business Bank, provides loans and pre- and post-application support to new entrepreneurs, including a year of free business mentoring for successful applicants. Since 2012, over 86,000 Start Up Loans worth over £769 million have been issued to new entrepreneurs. We are also investing £147 million through the Made Smarter Innovation programme to help forward-thinking UK manufacturers create new, green products and processes, slash carbon emissions, drive up productivity and create thousands of highly skilled new jobs across the country.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 12:39:38 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4742 label Biography information for Stuart Anderson

1350995

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.
	tabling member constituency	Halifax
	tabling member printed	Holly Lynch
	uin	41025
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The European Union has recently published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency, for travel purposes which is at the following link:</p><p> </p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p> </p><p>The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:15:23 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4472 label Biography information for Holly Lynch

1351014

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
	tabling member constituency	Meriden
	tabling member printed	Saqib Bhatti
	uin	41357
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.</p><p> </p><p>The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:10:14 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4818 label Biography information for Saqib Bhatti

1351023

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Quarantine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason Government policy makes a distinction between covid-19 vaccines received in the UK and those received overseas when deciding whether a traveller returning from an amber list country needs to quarantine.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	41240
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Government is currently undertaking extensive work to consider which regulators and associated vaccines we would recognise. It is important to consider which regulators have similar stringent standards of authorisation as the Medicines Healthcare products Regulatory Agency, which has some of the highest standards of quality, safety and efficacy in the world. This will then feed into discussions regarding quarantine from amber-listed countries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:22:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4682 label Biography information for Luke Pollard

1351044

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Vans: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent assessment he has made of vehicle supply shortages affecting the UK van sector; and what cross-departmental steps he is taking to help rectify those supply shortages.
	tabling member constituency	Ealing Central and Acton
	tabling member printed	Dr Rupa Huq
	uin	41074
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Government has regularly engaged with multiple stakeholders including the Department for Transport, manufacturers and automotive trade associations to discuss steps to help rectify supply chain shortages.</p><p> </p><p>The Government recognises the severity of the semiconductor shortage and its impacts on vehicle supply chains. BEIS officials are working with the Department for Digital, Culture, Media and Sport (DCMS) who are leading on this issue. DCMS is working closely with companies affected by this shortage to discuss interim support measures and supply solutions, as well as lobbying for a coordinated multilateral response through the G7. DCMS is also engaging bilaterally with key supplier countries like the US and Japan, to lobby for fair UK access to currently constrained supply and address systemic issues in the sector to avoid future repetition of the current shortage.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 12:56:58 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4511 label Biography information for Dr Rupa Huq